Zynex, Inc. (ZYXI) Granted FDA Clearance for Blood Volume Monitor
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Zynex, Inc. (ZYXI) Tops Q4 EPS by 1c, Revenues Beat; Offers Q1 & FY20 Revenue Guidance Above Consensus
February 27, 2020 4:50 PM ESTZynex, Inc. (NASDAQ: ZYXI) reported Q4 EPS of $0.09, $0.01 better than the analyst estimate of $0.08. Revenue for the quarter came in at $14.2 million versus the consensus estimate of $13.77 million.
2019 Fourth Quarter
Revenue increased 52% year over year to $14.2 millionOrders increased 129%Net income of $2.9 million; Diluted EPS $0.09Adjusted EBITDA increased 30% to $4.1 millionFourteenth consecutive quarter of positive net incomeThomas Sandgaard, CEO said: "In the fourth quarter, we posted revenue of $14.2... More
Zynex Inc. (ZYXI) PT Raised to $19.75 at B.Riley/FBR
February 21, 2020 10:48 AM ESTB.Riley/FBR analyst Marc Wiesenberger raised the price target on Zynex Inc. (NASDAQ: ZYXI) to $19.75 (from $12.00) while maintaining a Buy rating.... More
